(Q42255552)

19 October 2017

6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity (English)

1 reference

19 October 2017

1 reference

1 reference

Cuffari C

1

1 reference

19 October 2017

Théorêt Y

series ordinal

2

1 reference

19 October 2017

Latour S

series ordinal

3

1 reference

19 October 2017

Seidman G

series ordinal

4

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 September 1996

1 reference

19 October 2017

1 reference

19 October 2017

39

1 reference

19 October 2017

3

1 reference

19 October 2017

401-406

1 reference

Cellular pharmacology of 6-mercaptopurine in acute lymphoblastic leukemia

19 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383347

Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383347

6-Mercaptopurine: cytotoxicity and biochemical pharmacology in human malignant T-lymphoblasts

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383347

Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383347

Childhood leukaemia: a relationship between intracellular 6-mercaptopurine metabolites and neutropenia

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383347

A simple index of Crohn's-disease activity

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383347

The clinical pharmacology of 6-mercaptopurine

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383347

Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383347

Chronic intermittent elemental diet improves growth failure in children with Crohn's disease

26 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383347

Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383347

6-Mercaptopurine Therapy in Selected Cases of Corticosteroid-Dependent Crohn's Disease

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383347

Use of azathioprine or 6-mercaptopurine in the treatment of Crohn's disease

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383347

Long-term 6-mercaptopurine treatment in adolescents with Crohn's disease.

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1383347

Variable bioavailability of oral mercaptopurine. Is maintenance chemotherapy in acute lymphoblastic leukemia being optimally delivered?

17 August 2018

1 reference

12 December 2020

The effect of 6-mercaptopurine on natural killer-cell activities in Crohn's disease

1 reference

12 December 2020

6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity

1 reference

12 December 2020

Variable mercaptopurine metabolism and treatment outcome in childhood lymphoblastic leukemia

1 reference

12 December 2020

Azathioprine in the treatment of children with inflammatory bowel disease

1 reference

12 December 2020

Immunology of inflammatory bowel disease: summary of the proceedings of the Subcommittee on Immunosuppressive Use in IBD

1 reference

12 December 2020

Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Foru

1 reference

12 December 2020

Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease

1 reference

12 December 2020

Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease

1 reference

12 December 2020

Reversal of 6-mercaptopurine and 6-methylmercaptopurine ribonucleoside cytotoxicity by amidoimidazole carboxamide ribonucleoside in Molt F4 human malignant T-lymphoblasts

1 reference

12 December 2020

The role of leukopenia in the 6-mercaptopurine-induced remission of refractory Crohn's disease

1 reference

12 December 2020

High-performance liquid chromatographic assay of human red blood cell thiopurine methyltransferase activity

1 reference

12 December 2020

Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.39.3.401

1 reference

19 October 2017

1 reference

19 October 2017

PubMed publication ID

8949645

1 reference